Logo image
Pathophysiology of fetal microchimeric cells
Journal article   Open access   Peer reviewed

Pathophysiology of fetal microchimeric cells

Carol M Artlett
Clinica chimica acta, v 360(1), pp 1-8
2005
PMID: 15979602
url
http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.320.5182View

Abstract

Autoimmune disease Microchimerism Prenatal diagnosis Transfusion Organ transplantation Fetal cells
Microchimerism has been defined by the presence of a low number of circulating cells transferred from one individual to another. The transfer of microchimeric cells naturally takes place during pregnancy and occurs bi-directionally between the mother and fetus. Further, microchimerism can also be a result of blood transfusions and organ transplants. Microchimeric cells have been implicated in health and disease. Fetal microchimerism has been correlated with the hyporesponsiveness of the maternal immune system towards a fetal allograft and with the longevity of organ transplants. However, microchimeric cells have been implicated in the pathogenesis of autoimmune diseases including systemic sclerosis. In contrast, microchimeric cells were found to contribute to tissue repair. Much controversy exists around the role of microchimeric cells in the pathogenesis of certain diseases, and these cells in tissues may be a consequence rather than the cause of disease.

Metrics

15 Record Views
34 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#5 Gender Equality

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Medical Laboratory Technology
Logo image